Huidige functies Richard Peters
- 2023 - heden Non-executive chair, Pharming Group
- 2019 - heden Oprichter & executive chair, TellBio
Loopbaan Richard Peters
- 2019 - 2022 President & CEO, Yumanity Therapeutics
- 2016 - 2022 Oprichter & director, PIC Therapeutics
- 2019 - 2021 Corporate advisor, Merrimack Pharmaceuticals
- 2017 - 2019 President, CEO & director, Merrimack Pharmaceuticals
- 2015 - 2017 Senior vice president, head of global rare diseases & JAPAC specialty care BU head, Sanofi Genzyme
- 2014 - 2015 Mede-oprichter, investeerder & director, X4 Pharmaceuticals
- 2014 - 2014 Strategy development officer, Gemzyme
- 2011 - 2014 Division medical officer, Sanofi
- 2008 - 2011 Vice president, global & US medical affairs, Genzyme
- 2006 - 2008 Senior director medical affairs, Onyx Pharmaceuticals
- 2003 - 2006 Director medical affairs, Amgen
- 1997 - 2003 CEO, Mednav
- 1993 - 1997 Docent geneeskunde, Massachusetts General Hospital
Opleiding Richard Peters
- Farmacologie, Medical University of South Carolina
- Howard Hughes postdoctorale opleiding, Harvard Medical School
- Geneeskunde, Massachusetts General Hospital
Overige vermeldingen
Overige nevenfuncties
- Non-executive director, Kineta (sinds 2022)
- Non-executive director, Aprea Therapeutics (sinds 2020)
- Investor & corporate advisor, Aura Biosciences (sinds 2014)
- Non-executive director, Kineta (sinds 2022)
- Non-executive director, Aprea Therapeutics (sinds 2020)
- Investor & corporate advisor, Aura Biosciences (sinds 2014)